Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tore Saxne

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Arthritis Care & Research|May 28, 2010
Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern SwedenAnders Gülfe, Lars Erik Kristensen, Tore Saxne, et al.
Arthritis Research & Therapy|October 8, 2016
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritisAndré Struglics, Marcin Okroj, Per Swärd, et al.
Arthritis and Rheumatism|June 28, 2006
The heritable determinants of cartilage oligomeric matrix proteinFrances M K Williams, Toby Andrew, Tore Saxne, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 4, 2012
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosisKristina Rydell-Törmänen, Kristofer Andréasson, Roger Hesselstrand, et al.
Arthritis Research & Therapy|September 24, 2004
Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]Helena Forsblad d'Elia, Stephan Christgau, Lars-Ake Mattsson, et al.
The Journal of Rheumatology|May 5, 2009
Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern SwedenMaria K Söderlin, Lennart T H Jacobsson, Ingemar F Petersson, et al.
Arthritis Care & Research|August 29, 2013
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohortLars Erik Kristensen, Henning Bliddal, Robin Christensen, et al.
The Journal of Biological Chemistry|April 25, 2012
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascadeMarcin Okroj, Emelie Holmquist, Jonatan Sjölander, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register StudyHanna Källmark, Jon T Einarsson, Jan-Åke Nilsson, et al.
Arthritis and Rheumatism|October 2, 2007
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markersSteven Young-Min, Tim Cawston, Nicola Marshall, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Arthritis Care & Research|May 28, 2010
Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern SwedenAnders Gülfe, Lars Erik Kristensen, Tore Saxne, et al.
Arthritis Research & Therapy|October 8, 2016
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritisAndré Struglics, Marcin Okroj, Per Swärd, et al.
Arthritis and Rheumatism|June 28, 2006
The heritable determinants of cartilage oligomeric matrix proteinFrances M K Williams, Toby Andrew, Tore Saxne, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 4, 2012
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosisKristina Rydell-Törmänen, Kristofer Andréasson, Roger Hesselstrand, et al.
Arthritis Research & Therapy|September 24, 2004
Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]Helena Forsblad d'Elia, Stephan Christgau, Lars-Ake Mattsson, et al.
The Journal of Rheumatology|May 5, 2009
Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern SwedenMaria K Söderlin, Lennart T H Jacobsson, Ingemar F Petersson, et al.
Arthritis Care & Research|August 29, 2013
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohortLars Erik Kristensen, Henning Bliddal, Robin Christensen, et al.
The Journal of Biological Chemistry|April 25, 2012
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascadeMarcin Okroj, Emelie Holmquist, Jonatan Sjölander, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register StudyHanna Källmark, Jon T Einarsson, Jan-Åke Nilsson, et al.
Arthritis and Rheumatism|October 2, 2007
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markersSteven Young-Min, Tim Cawston, Nicola Marshall, et al.
Pageof 9